Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print August 23, 2007
DOI: 10.2337/dc07-0108

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
dc07-0108v1
dc07-0108v2
30/12/3053    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Severinsen, K.
Right arrow Articles by Andersen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Severinsen, K.
Right arrow Articles by Andersen, H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Atrophy of foot muscles in diabetic patients can be detected with ultrasonography.

Kaare Severinsen, MD*, Annette Obel, MD**, Johannes Jakobsen* and Henning Andersen*

*Neurology
**Neuroradiology, Aarhus University Hospital, DENMARK

hande{at}as.aaa.dk

ABSTRACT

Objective: To establish a bedside test with ultrasonography for evaluation of foot muscle atrophy in diabetic patients.

Research Design and Methods: Thickness and cross sectional area of the extensor digitorum brevis muscle (EDB) and of the muscles of the first interstitium (MIL) were determined in 26 diabetic patients and in 26 matched control subjects using ultrasonography. To estimate the validity findings were related to the total volume of all foot muscles determined at magnetic resonance imaging (MRI-FMvol). Furthermore, the relations of ultrasonographic estimates to nerve conduction, sensory perception tresholds and clinical condition were established.

Results: In diabetic patients the ultrasonographic thickness of EDB (U-EDBt) was 6.4 ± 2.1 mm (mean ± SD) vs. 9.0 ± 1.0 mm in controls (p<0.001), thickness of MIL (U-MILt) was 29.6 ± 8.3 mm vs. 40.2 ± 3.6 mm in controls (p<0.001) and the cross sectional area of EDB (U-EDBCSA) was 116 ± 65 mm2 vs. 214 ± 38 mm2 in controls (p<0.001). The MRI-FMvol was directly related to U-EDBt (r=0.77), U-MILt (r=0.71) and to U-EDBCSA (r=0.74). U-EDBt and U-MILt were thinner in neuropathic than in non-neuropathic diabetic patients (5.8 ± 2.1 mm vs. 7.5 ± 1.7 mm (p<0.05) and 28.3 ± 8.8 mm vs. 35.6 ± 4.3 mm (p<0.03), respectively).

Conclusions: Atrophy of intrinsic foot muscles determined at ultrasonography is directly related to foot muscle volume determined by MRI and to various measures of diabetic neuropathy. Ultrasonography seems to be useful for detection of foot muscle atrophy in diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.